EATG » Cure

Cure

Discovery of how HIV hedges its bets opens the door to new therapies

Scientists at Gladstone reveal how the virus decides between fates SAN FRANCISCO, CA, May 10, 2018 — A stem cell is one with infinite possibilities. So, for decades, scientists have…

Study challenges ‘shock and kill’ approach to eliminating HIV

Researchers have provided new insight into the cellular processes behind the 'shock and kill' approach to curing HIV, which they say challenges the effectiveness of the treatment. Their study, published…

Gene editing holds promise for shrinking HIV ‘reservoir’

Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals. By transplanting…

Gene-edited stem cells show promise against HIV in non-human primates

Edited cells reduce size of 'viral reservoirs' that could reactivate to produce more virus copies Gene editing of bone marrow stem cells in pigtail macaques infected with simian/human immunodeficiency virus…

Top HIV cure research team refutes major recent results on how to identify HIV persistence

Collaborative effort sets the record straight on the use of CD32 as a biomarker to measure HIV reservoirs. PHILADELPHIA — (April 18, 2018) — An international team focused on HIV…

Has basic science in HIV research stalled?

Now that effective therapies for active HIV infection are broadly available, there should be renewed focus on basic science regarding HIV, said experts contacted by MedPage Today. Without it, they…

HIV i-Base: HTB, special CROI issue

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This is the second issue of HTB to lead with reports from CROI 2018, the main annual HIV…

HIVACAR: EATG reports from the second general assembly of the consortium

On March 15-16 the European AIDS Treatment Group participated in the second general assembly meeting of the HIVACAR consortium in Digem (Belgium). The EATG in collaboration with the Complutense University…

HIV i-Base: HTB, first reports from CROI 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. This edition of HTB includes the first reports from CROI 2018, with additional reports following in subsequent issues.…

Targeting HIV: Moving closer to a potential cure

Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains ROCKVILLE, Md., March 13, 2018: A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the…

1 2 3 16